Literature DB >> 30606729

Continuum of Host-Gut Microbial Co-metabolism: Host CYP3A4/3A7 are Responsible for Tertiary Oxidations of Deoxycholate Species.

Jian Zhang1, Ling-Zhi Gao1, Yu-Jie Chen1, Ping-Ping Zhu1, Shan-Shan Yin1, Ming-Ming Su1, Yan Ni1, Jia Miao1, Wen-Lin Wu1, Hong Chen1, Kim L R Brouwer1, Chang-Xiao Liu1, Liang Xu1, Wei Jia2, Ke Lan2.   

Abstract

The gut microbiota modifies endogenous primary bile acids (BAs) to produce exogenous secondary BAs, which may be further metabolized by cytochrome P450 enzymes (P450s). Our primary aim was to examine how the host adapts to the stress of microbe-derived secondary BAs by P450-mediated oxidative modifications on the steroid nucleus. Five unconjugated tri-hydroxyl BAs that were structurally and/or biologically associated with deoxycholate (DCA) were determined in human biologic samples by liquid chromatography-tandem mass spectrometry in combination with enzyme-digestion techniques. They were identified as DCA-19-ol, DCA-6β-ol, DCA-5β-ol, DCA-6α-ol, DCA-1β-ol, and DCA-4β-ol based on matching in-laboratory synthesized standards. Metabolic inhibition assays in human liver microsomes and recombinant P450 assays revealed that CYP3A4 and CYP3A7 were responsible for the regioselective oxidations of both DCA and its conjugated forms, glycodeoxycholate (GDCA) and taurodeoxycholate (TDCA). The modification of secondary BAs to tertiary BAs defines a host liver (primary BAs)-gut microbiota (secondary BAs)-host liver (tertiary BAs) axis. The regioselective oxidations of DCA, GDCA, and TDCA by CYP3A4 and CYP3A7 may help eliminate host-toxic DCA species. The 19- and 4β-hydroxylation of DCA species demonstrated outstanding CYP3A7 selectivity and may be useful as indicators of CYP3A7 activity.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30606729      PMCID: PMC6378331          DOI: 10.1124/dmd.118.085670

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity.

Authors:  Yu-Jie Chen; Jian Zhang; Ping-Ping Zhu; Xian-Wen Tan; Qiu-Hong Lin; Wen-Xia Wang; Shan-Shan Yin; Ling-Zhi Gao; Ming-Ming Su; Chang-Xiao Liu; Liang Xu; Wei Jia; Irina F Sevrioukova; Ke Lan
Journal:  Drug Metab Dispos       Date:  2019-03-27       Impact factor: 3.922

2.  Compensatory Transition of Bile Acid Metabolism from Fecal Disposition of Secondary Bile Acids to Urinary Excretion of Primary Bile Acids Underlies Rifampicin-Induced Cholestasis in Beagle Dogs.

Authors:  LanLan Gui; QingLiang Wu; YiTing Hu; WuShuang Zeng; XianWen Tan; PingPing Zhu; XueJing Li; Lian Yang; Wei Jia; ChangXiao Liu; Ke Lan
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-22

3.  Effect of a Flaxseed Lignan Intervention on Circulating Bile Acids in a Placebo-Controlled Randomized, Crossover Trial.

Authors:  Sandi L Navarro; Lisa Levy; Keith R Curtis; Isaac Elkon; Orsalem J Kahsai; Hamza S Ammar; Timothy W Randolph; Natalie N Hong; Fausto Carnevale Neto; Daniel Raftery; Robert S Chapkin; Johanna W Lampe; Meredith A J Hullar
Journal:  Nutrients       Date:  2020-06-19       Impact factor: 5.717

4.  Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers.

Authors:  Xue-Qing Li; Roslyn Stella Thelingwani; Leif Bertilsson; Ulf Diczfalusy; Tommy B Andersson; Collen Masimirembwa
Journal:  J Pers Med       Date:  2021-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.